| TPT1 |
TPT1: Translationally-controlled tumor protein |
PDCD10 |
PDCD10, CCM3, TFAR15: Programmed cell death protein 10 |
0.635 |
Evidence |
|
| ORC5L |
ORC5L: Origin recognition complex subunit 5 |
CAD |
CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase |
0.635 |
Evidence |
|
| ARPC3 |
ARPC3, ARC21: Actin-related protein 2/3 complex subunit 3 |
SFRS3 |
SFRS3, SRP20: Splicing factor, arginine/serine-rich 3 |
0.635 |
Evidence |
|
| RELB |
RELB: Transcription factor RelB |
NFKBIB |
NFKBIB, IKBB, TRIP9: NF-kappa-B inhibitor beta |
0.635 |
Evidence |
|
| MSH2 |
MSH2: DNA mismatch repair protein Msh2 |
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
0.635 |
Evidence |
|
| NDUFS4 |
NDUFS4: NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial pre |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.635 |
Evidence |
O
|
| VAMP3 |
VAMP3, SYB3: Vesicle-associated membrane protein 3 |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
0.632 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
ORC3L |
ORC3L, LATHEO: Origin recognition complex subunit 3 |
0.632 |
Evidence |
|
| MCM5 |
MCM5, CDC46: DNA replication licensing factor MCM5 |
ORC3L |
ORC3L, LATHEO: Origin recognition complex subunit 3 |
0.632 |
Evidence |
|
| MCM5 |
MCM5, CDC46: DNA replication licensing factor MCM5 |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
0.632 |
Evidence |
|
| RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
RAB9A |
RAB9, RAB9A: Ras-related protein Rab-9 |
0.632 |
Evidence |
|
| RHOQ |
RHOQ, ARHQ, RASL7A, TC10: Rho-related GTP-binding protein RhoQ precursor |
COPZ1 |
COPZ1, COPZ, CGI-120, HSPC181: Coatomer subunit zeta-1 |
0.632 |
Evidence |
|
| LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
0.632 |
Evidence |
|
| SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.632 |
Evidence |
|
| CCR5 |
CCR5: CCR5 receptor (Fragment) |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.632 |
Evidence |
O
|
| ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
SERPINA3 |
IPI00550991 |
0.632 |
Evidence |
|
| ICAM5 |
ICAM5, TLCN, TLN: Intercellular adhesion molecule 5 precursor |
RDX |
RDX: Radixin |
0.632 |
Evidence |
|
| CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
TSHR |
IPI00386365 |
0.632 |
Evidence |
|
| USP7 |
USP7, HAUSP: Ubiquitin carboxyl-terminal hydrolase 7 |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
0.632 |
Evidence |
|
| CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
TSHR |
IPI00386365 |
0.632 |
Evidence |
|
| CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.632 |
Evidence |
|
| GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
0.632 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.632 |
Evidence |
|
| TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
0.632 |
Evidence |
|
| MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.632 |
Evidence |
|
-